New Results Released from the ACHIEVE Study

The ACHIEVE study is one of six that are part of a global collaborative effort to evaluate the  noninferiority of 3-month vs 6-month oxaliplatin-based adjuvant chemotherapy in patients with stage III colon cancer.

Source: CancerNetwork - September 17, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news